Early initiation of SGLT2 inhibitors in acute myocardial infarction and cardiovascular outcomes, an updated systematic review and meta-analysis

Early initiation of SGLT2 inhibitors in acute myocardial infarction and cardiovascular outcomes, an updated systematic review and meta-analysis

Abstract Background Sodium-glucose cotransporter-2 (SGLT2) inhibitors increase survival rate in heart failure, but early initiation of these agents after acute myocardial infarction (MI) is controversial. Methods We searched PubMed, Scopus, Embase, and ClinicalTrial.gov for randomized clinical trial...

Full description

Saved in:
Bibliographic Details
Main Authors: Davood Semirani-Nezhad, Hamidreza Soleimani, Morvarid Taebi, Khatere Roozbehi, Soodeh Jahangiri, Babak Sattartabar, Fatemeh Takaloo, Bahar parastooei, Erfan Asfa, Danyal Salabat, Mohammad Mobin Alishahi, Fatemeh Mosayebi, Yaser jenab, Rahul Gupta, Toshiki Kuno, Wilbert Aronow, Kaveh Hosseini
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Sodium-Glucose transporter 2 inhibitors
Myocardial infarction
Acute coronary syndrome
Heart failure
Online Access:https://doi.org/10.1186/s12872-025-04992-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12872-025-04992-2

Similar Items